{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:34:17Z","timestamp":1780914857748,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00467-013-2431-x","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T02:05:02Z","timestamp":1361239502000},"page":"1261-1266","source":"Crossref","is-referenced-by-count":31,"title":["Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5"],"prefix":"10.1007","volume":"28","author":[{"given":"Pornpimol","family":"Rianthavorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantipa","family":"Boonyapapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"2431_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1525-139X.2011.00986.x","volume":"25","author":"JG Heaf","year":"2012","unstructured":"Heaf JG, Joffe P, Marckmann P (2012) Vitamin d and stage 5 chronic kidney disease: A new paradigm? Semin Dial 25:50\u201358","journal-title":"Semin Dial"},{"key":"2431_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jn\/135.2.317","volume":"135","author":"BW Hollis","year":"2005","unstructured":"Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317\u2013322","journal-title":"J Nutr"},{"key":"2431_CR3","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000098645","volume":"105","author":"G Saab","year":"2007","unstructured":"Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW (2007) Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105:c132\u2013138","journal-title":"Nephron Clin Pract"},{"key":"2431_CR4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004\u20131013","journal-title":"Kidney Int"},{"key":"2431_CR5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/87.6.1631","volume":"87","author":"AY Wang","year":"2008","unstructured":"Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J (2008) Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study. Am J Clin Nutr 87:1631\u20131638","journal-title":"Am J Clin Nutr"},{"key":"2431_CR6","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/S0272-6386(05)00870-X","volume":"46","author":"National Kidney Foundation","year":"2005","unstructured":"National Kidney Foundation (2005) K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:S48\u201352","journal-title":"Am J Kidney Dis"},{"key":"2431_CR7","first-page":"S1","volume":"113","author":"KDIGO","year":"2009","unstructured":"KDIGO (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013130","journal-title":"Kidney Int Suppl"},{"key":"2431_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0301-472X(02)00789-0","volume":"30","author":"DB Alon","year":"2002","unstructured":"Alon DB, Chaimovitz C, Dvilansky A, Lugassy G, Douvdevani A, Shany S, Nathan I (2002) Novel role of 1,25(OH)(2)D(3) in induction of erythroid progenitor cell proliferation. Exp Hematol 30:403\u2013409","journal-title":"Exp Hematol"},{"key":"2431_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00277-009-0850-3","volume":"89","author":"JJ Sim","year":"2010","unstructured":"Sim JJ, Lac PT, Liu IL, Meguerditchian SO, Kumar VA, Kujubu DA, Rasgon SA (2010) Vitamin D deficiency and anemia: A cross-sectional study. Ann Hematol 89:447\u2013452","journal-title":"Ann Hematol"},{"key":"2431_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000202632","volume":"30","author":"J Kendrick","year":"2009","unstructured":"Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol 30:64\u201372","journal-title":"Am J Nephrol"},{"key":"2431_CR11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2009.551","volume":"77","author":"NM Patel","year":"2010","unstructured":"Patel NM, Gutierrez OM, Andress DL, Coyne DW, Levin A, Wolf M (2010) Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77:715\u2013720","journal-title":"Kidney Int"},{"key":"2431_CR12","doi-asserted-by":"crossref","first-page":"c373","DOI":"10.1159\/000321521","volume":"117","author":"Z Kiss","year":"2011","unstructured":"Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I (2011) Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 117:c373\u2013378","journal-title":"Nephron Clin Pract"},{"key":"2431_CR13","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","volume":"89","author":"LA Armas","year":"2004","unstructured":"Armas LA, Hollis BW, Heaney RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89:5387\u20135391","journal-title":"J Clin Endocrinol Metab"},{"key":"2431_CR14","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"2431_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/JN.2010.1830","volume":"24","author":"VA Kumar","year":"2011","unstructured":"Kumar VA, Kujubu DA, Sim JJ, Rasgon SA, Yang PS (2011) Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol 24:98\u2013105","journal-title":"J Nephrol"},{"key":"2431_CR16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(02)70081-4","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39:S1\u2013266","journal-title":"Am J Kidney Dis"},{"key":"2431_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571\u2013590","journal-title":"Pediatr Clin North Am"},{"key":"2431_CR18","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.010","volume":"47","author":"National Kidney Foundation","year":"2006","unstructured":"National Kidney Foundation (2006) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47:S11\u2013145","journal-title":"Am J Kidney Dis"},{"key":"2431_CR19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D Somjen","year":"2005","unstructured":"Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N (2005) 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111:1666\u20131671","journal-title":"Circulation"},{"key":"2431_CR20","doi-asserted-by":"crossref","first-page":"R980","DOI":"10.1186\/bcr1332","volume":"7","author":"U Segersten","year":"2005","unstructured":"Segersten U, Holm PK, Bjorklund P, Hessman O, Nordgren H, Binderup L, Akerstrom G, Hellman P, Westin G (2005) 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res 7:R980\u2013986","journal-title":"Breast Cancer Res"},{"key":"2431_CR21","first-page":"31","volume":"20","author":"I Blazsek","year":"1996","unstructured":"Blazsek I, Farabos C, Quittet P, Labat ML, Bringuier AF, Triana BK, Machover D, Reynes M, Misset JL (1996) Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias. Cancer Detect Prev 20:31\u201342","journal-title":"Cancer Detect Prev"},{"key":"2431_CR22","first-page":"144","volume":"14","author":"A Dusso","year":"1994","unstructured":"Dusso A, Brown A, Slatopolsky E (1994) Extrarenal production of calcitriol. Semin Nephrol 14:144\u2013155","journal-title":"Semin Nephrol"},{"key":"2431_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0272-6386(97)90339-5","volume":"29","author":"P Barany","year":"1997","unstructured":"Barany P, Divino Filho JC, Bergstrom J (1997) High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565\u2013568","journal-title":"Am J Kidney Dis"},{"key":"2431_CR24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"2431_CR25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754\u2013759","journal-title":"Am J Clin Nutr"},{"key":"2431_CR26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1523-1755.1998.00084.x","volume":"54","author":"M Goicoechea","year":"1998","unstructured":"Goicoechea M, Martin J, de Sequera P, Quiroga JA, Ortiz A, Carreno V, Caramelo C (1998) Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337\u20131343","journal-title":"Kidney Int"},{"key":"2431_CR27","first-page":"19","volume":"9","author":"G Coen","year":"1983","unstructured":"Coen G, Taccone Gallucci M, Bonucci E, Ballanti P, Bianchi AR, Bianchini G, Matteucci MC, Mazzaferro S, Picca S, Taggi F, Cinotti GA, Casciani CU (1983) 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: Comparison of combined versus 1,25(OH)2D3 administration alone. Miner Electrolyte Metab 9:19\u201327","journal-title":"Miner Electrolyte Metab"},{"issue":"Suppl","key":"2431_CR28","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ASN.0000093369.09194.12","volume":"15","author":"D Brancaccio","year":"2004","unstructured":"Brancaccio D, Cozzolino M, Gallieni M (2004) Hyperparathyroidism and anemia in uremic subjects: A combined therapeutic approach. J Am Soc Nephrol 15[Suppl]:S21\u201324","journal-title":"J Am Soc Nephrol"},{"key":"2431_CR29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","volume":"328","author":"DS Rao","year":"1993","unstructured":"Rao DS, Shih MS, Mohini R (1993) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171\u2013175","journal-title":"N Engl J Med"},{"key":"2431_CR30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jpeds.2008.12.006","volume":"154","author":"W Seeherunvong","year":"2009","unstructured":"Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M (2009) Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 154:906\u2013911","journal-title":"J Pediatr"},{"key":"2431_CR31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-008-1041-5","volume":"24","author":"V Belostotsky","year":"2009","unstructured":"Belostotsky V, Mughal Z, Webb NJ (2009) A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease. Pediatr Nephrol 24:625\u2013626","journal-title":"Pediatr Nephrol"},{"key":"2431_CR32","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00467-008-0842-x","volume":"23","author":"S Menon","year":"2008","unstructured":"Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23:1831\u20131836","journal-title":"Pediatr Nephrol"},{"key":"2431_CR33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-010-1611-1","volume":"25","author":"P Rianthavorn","year":"2010","unstructured":"Rianthavorn P, Ettenger RB, Salusky IB, Kuizon BD (2010) Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. Pediatr Nephrol 25:2311\u20132319","journal-title":"Pediatr Nephrol"},{"key":"2431_CR34","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.02380607","volume":"2","author":"S Fishbane","year":"2007","unstructured":"Fishbane S, Besarab A (2007) Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Clin J Am Soc Nephrol 2:1274\u20131282","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2431-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2431-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:47:15Z","timestamp":1562694435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2431-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}